University Hospital of Bern, Department of Gynecological Endocrinology & Reproductive Medicine
Bern, 3010, Switzerland
Location status: Recruiting
NCT Number: NCT06831890
The goal of the clinical trial is to assess whether the data collected from wearable devices can reduce the uncertainty in predicting the cardiovascular disease (CVD) risk in women aged 40-69 years in a situation where information about the blood pressure and blood lipids are unavailable.
Participants will:
* Complete a screening and baseline assessment, including blood sample collection and vital parameter measurement. * Wear a wearable device for one week. * Fill in a work and sleep journal. * Complete a last visit assessment.
Interested in participating?
Request Info40 year–69 year
Female
Observational
Bern, 3010, Switzerland
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: After 7-day wearable data collection period.
Assessment of the reduction in prediction uncertainty of cardiovascular disease (CVD) risk in women aged 40-69 years when wearable-derived data (e.g., heart rate, daily step count) is used to replace missing physician-recorded inputs (e.g., blood pressure and lipid levels). The reduction will be quantified using the Continuous Ranked Probability Score (CRPS), whereby smaller CRPS values indicate improved performance. An improvement is considered substantial if introducing wearable data reduces CRPS by at least 5%.
Time frame: After 7-day wearable data collection period.
Identifying specific data from wearable devices that most effectively reduce uncertainty in predicting CVD risk in the absence of information on blood pressure, blood lipids, and the presence or absence of metabolic syndrome. To achieve this, statistical and machine learning methods capable of handling irregularly samples time series of bio-signals recorded by the wearable devices will be applied.
Contact information is provided by the study sponsor or research team.
Insel Gruppe AG, University Hospital Bern
Other
Surrogating Physician-recorded SCORE2 Risk Calculator Inputs by Using Auxiliary Data - A Cross-sectional Study in Apparently Healthy Women Aged 40 to 69 Years (Frauenherzen)
Acronym: Frauenherzen
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06487130
Behavior, Behavioral Symptoms
Adelaide, Australia
View Trial DetailsNCT05647876
Behavior, Cardiovascular Diseases
Copenhagen, Denmark
View Trial DetailsNCT00005152
Angina Pectoris, Brain Diseases
View Trial DetailsNCT07394049
Cardiovascular Diseases, Hormone Replacement Therapy
Berlin, Germany
View Trial Details